Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name:L929 Strain State : Validation of tumorigenic capacity | Cat. NO.:NM-S39A
mouse fibroblasts cell line
Strain Name:KP-4 Strain State : Validation of tumorigenic capacity completed | Cat. NO.:NM-Y07
Human tumor cell line secreting parathyroid hormone-related peptide (PTHrP) established from pancreatic tumor.
Strain Name:INS-1 Strain State : Validation of tumorigenic capacity | Cat. NO.:NM-S10
Rat islet cell line
Strain Name:NIH/3T3 Strain State : Validation of tumorigenic capacity | Cat. NO.:NM-S08
mouse embryonic cell line
Strain Name:NCI-H929 [H929] Strain State : Validation of tumorigenic capacity | Cat. NO.:NM-GS03
Human myeloma cell line
Strain Name:SW1573 Strain State : Validation of tumorigenic capacity completed | Cat. NO.:NM-FX04
The SW 1573 line was established in 1977 by A. Leibovitz from an alveolar cell carcinoma.
Strain Name:WEHI 164 Strain State : Validation of tumorigenic capacity | Cat. NO.:NM-S25A
Mouse fibrosarcoma cell line
Strain Name:P815 Strain State : Validation of tumorigenic capacity | Cat. NO.:NM-S36A
Mouse mastocytoma cell line
Strain Name:U251 Strain State : Validation of tumorigenic capacity completed | Cat. NO.:NM-N03
Human glioblastoma cell line
Strain Name:Renca Strain State : Validation of tumorigenic capacity completed | Cat. NO.:NM-S27A
The Renca cell line was derived from a tumor that arose spontaneously as a renal cortical adenocarcinoma in Balb/cCr mice.
Please fill in the order form and we will contact you within 2 working days.